© 1996 Oxford University Press
research-article |
Selenium-enriched garlic inhibits the early stage but not the late stage of mammary carcinogenesis
1Department of Surgical Oncology, Elm & Carlton Streets, Roswell Park Cancer Institute Buffalo, NY 14263
2Department of Fruit and Vegetable Science, Cornell University Ithaca, NY 14853
3Division of Laboratory Research, AMC Cancer Research Center Denver, CO 80214, USA
4To whom correspondence should be addressed
Previous work has shown that the efficacy of cancer prevention by selenium-enriched garlic (Se-garlic) is primarily dependent on the action of selenium. Additionally, supplementation of Se-garlic inhibited the post-initiation phase of mammary carcinogenesis when it was given continuously to the animals. In this report, experiments were carried out in which treatment with the Se-garlic was started after carcinogen dosing (DMBA or MNU) but was restricted to either the early or late stage of neoplastic progression. The results from these two models showed that a short-term exposure to the Se-garlic for 1 month immediately following carcinogen administration was just as effective in cancer prevention as the continuous exposure regimen (5 months), suggesting that the Se-garlic may irreversibly alter the process of clonal expansion and/or selection of transformed cells during their early stage of development. Plasma and mammary tissue selenium levels essentially returned to basal levels at 1 month after withdrawal of supplementation. These observations imply that the outcome of cancer protection by short-term Se-garlic intervention was not due to a slow turnover, and therefore a lingering presence, of selenium in the target organ or in the circulation. The above finding was in contrast to that of a second study in which Se-garlic was supplemented starting at 13 weeks after carcinogen treatment With this protocol, the number of new tumors and the number of new tumor-bearing rats found during the intervention period (weeks 13 to 22) were not statistically different between the control and supplemented groups, suggesting that Se-garlic had a minimal effect on the later stages of mammary carcinogenesis.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  L. Wang, M. J.L. Bonorden, G.-x. Li, H.-J. Lee, H. Hu, Y. Zhang, J. D. Liao, M. P. Cleary, and J. Lu Methyl-Selenium Compounds Inhibit Prostate Carcinogenesis in the Transgenic Adenocarcinoma of Mouse Prostate Model with Survival Benefit Cancer Prevention Research, May 1, 2009; 2(5): 484 - 495. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Jiang, C. Jiang, H. Pei, L. Wang, J. Zhang, H. Hu, and J. Lu In vivo molecular mediators of cancer growth suppression and apoptosis by selenium in mammary and prostate models: lack of involvement of gadd genes Mol. Cancer Ther., March 1, 2009; 8(3): 682 - 691. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Zhang and H. Zarbl Chemopreventive Doses of Methylselenocysteine Alter Circadian Rhythm in Rat Mammary Tissue Cancer Prevention Research, July 1, 2008; 1(2): 119 - 127. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Bruzelius, T. Hoac, R. Sundler, G. Onning, and B. Akesson Occurrence of Selenoprotein Enzyme Activities and mRNA in Bovine Mammary Tissue J Dairy Sci, February 1, 2007; 90(2): 918 - 927. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Dong, D. Lisk, E. Block, and C. Ip Characterization of the Biological Activity of {{gamma}}-Glutamyl-Se- methylselenocysteine: A Novel, Naturally Occurring Anticancer Agent from Garlic Cancer Res., April 1, 2001; 61(7): 2923 - 2928. [Abstract] [Full Text]
|
|
|
|
|
|
C. Jiang, Z. Wang, H. Ganther, and J. Lu Caspases as Key Executors of Methyl Selenium-induced Apoptosis (Anoikis) of DU-145 Prostate Cancer Cells Cancer Res., April 1, 2001; 61(7): 3062 - 3070. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. A. Milner A Historical Perspective on Garlic and Cancer J. Nutr., March 1, 2001; 131(3): 1027S - 1031. [Abstract] [Full Text]
|
|
|
|
|
|
A. T. Fleischauer and L. Arab Garlic and Cancer: A Critical Review of the Epidemiologic Literature J. Nutr., March 1, 2001; 131(3): 1032S - 1040. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. Ip, H. J. Thompson, and H. E. Ganther Selenium Modulation of Cell Proliferation and Cell Cycle Biomarkers in Normal and Premalignant Cells of the Rat Mammary Gland Cancer Epidemiol. Biomarkers Prev., January 1, 2000; 9(1): 49 - 54. [Abstract] [Full Text]
|
|
|
|
|
|
C. Ip Lessons from Basic Research in Selenium and Cancer Prevention J. Nutr., November 1, 1998; 128(11): 1845 - 1854. [Abstract] [Full Text]
|
|